As of 2024-07-27, the Relative Valuation of Charles River Laboratories International Inc (CRL) is 287.19 USD. This relative valuation is based on P/E multiples. With the latest stock price at 233.47 USD, the upside of Charles River Laboratories International Inc based on Relative Valuation is 23.0%.
The range of the Relative Valuation is 258.47 - 315.12 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.3x - 35.0x | 31.8x |
| Forward P/E multiples | 26.6x - 28.1x | 27.1x |
| Fair Price | 258.47 - 315.12 | 287.19 |
| Upside | 10.7% - 35.0% | 23.0% |
| Date | P/E |
| 2024-07-26 | 27.41 |
| 2024-07-25 | 26.04 |
| 2024-07-24 | 26.11 |
| 2024-07-23 | 25.86 |
| 2024-07-22 | 26.72 |
| 2024-07-19 | 25.62 |
| 2024-07-18 | 25.66 |
| 2024-07-17 | 26.19 |
| 2024-07-16 | 26.68 |
| 2024-07-15 | 25.38 |
| 2024-07-12 | 25.38 |
| 2024-07-11 | 24.75 |
| 2024-07-10 | 23.79 |
| 2024-07-09 | 23.69 |
| 2024-07-08 | 23.77 |
| 2024-07-05 | 23.44 |
| 2024-07-03 | 23.64 |
| 2024-07-02 | 23.65 |
| 2024-07-01 | 23.86 |
| 2024-06-28 | 24.25 |
| 2024-06-27 | 24.34 |
| 2024-06-26 | 24.26 |
| 2024-06-25 | 24.23 |
| 2024-06-24 | 24.63 |
| 2024-06-21 | 24.84 |
| 2024-06-20 | 24.61 |
| 2024-06-18 | 24.63 |
| 2024-06-17 | 24.46 |
| 2024-06-14 | 24.59 |
| 2024-06-13 | 24.94 |
| 2024-06-12 | 25.10 |
| 2024-06-11 | 24.70 |
| 2024-06-10 | 25.18 |
| 2024-06-07 | 25.21 |
| 2024-06-06 | 26.01 |
| 2024-06-05 | 25.37 |
| 2024-06-04 | 24.68 |
| 2024-06-03 | 24.41 |
| 2024-05-31 | 24.47 |
| 2024-05-30 | 24.62 |
| 2024-05-29 | 24.82 |
| 2024-05-28 | 25.18 |
| 2024-05-24 | 25.50 |
| 2024-05-23 | 25.54 |
| 2024-05-22 | 25.71 |
| 2024-05-21 | 26.00 |
| 2024-05-20 | 26.18 |
| 2024-05-17 | 26.01 |
| 2024-05-16 | 26.38 |
| 2024-05-15 | 27.30 |